[en] BACKGROUND & AIMS: Functional dyspepsia (FD) is subdivided into postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS) according to the Rome III consensus. In clinical practice, there is a major overlap between these subgroups. The Rome IV criteria included postprandially occurring symptoms in the PDS subgroup. We aimed to analyze the effects of the Rome IV criteria, compared with Rome III, on FD subgroups in patients recruited from secondary care. METHODS: Patients with FD (n [ 224; mean age, 43-1 y; 77% women) were recruited from secondarycare units in Belgium and filled out symptom questionnaires, allowing subdivision according to Rome III and Rome IV criteria and identification of postprandial symptoms. Symptom patterns and demographics were compared between the subgroups. Statistical analysis was performed using the t test and the Fisher exact test. RESULTS: According to the Rome III criteria, 25% of participants had PDS, 8% had EPS, and 67% had an overlap. Postprandial fullness, early satiation, and bloating were present in significantly more patients in the PDS and overlap groups than the EPS group (P < .0001). A higher proportion of patients in the overlap group showed symptoms such as postprandial epigastric pain and nausea than in the EPS group (both P £ .02). With the Rome IV criteria, the overlap group was reduced to 35%; 57% of patients were considered to have PDS and 8% to have EPS. Postprandial pain was significantly more prevalent in the PDS than in the EPS group (P £ .002), and postprandial nausea was significantly more prevalent in the PDS group than the overlap group (P [ .007). CONCLUSIONS: Compared with Rome III criteria, the Rome IV criteria significantly reduces the overlap between PDS and EPS groups. Studies are needed to determine if Rome IV subgroups are associated differently with psychological comorbidities and treatment responses.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Van Den Houte, Karen; Translational Research Center for Gastrointestinal Diseases, University of Leuven, Leuven, Belgium
Carbone, Florencia; Translational Research Center for Gastrointestinal Diseases, University of Leuven, Leuven, Belgium
Goelen, Nick ; Translational Research Center for Gastrointestinal Diseases, University of Leuven, Leuven, Belgium
Schol, Jolien ; Translational Research Center for Gastrointestinal Diseases, University of Leuven, Leuven, Belgium
Masuy, Imke ; Translational Research Center for Gastrointestinal Diseases, University of Leuven, Leuven, Belgium
Arts, Joris; Maagdarm en Leverziekten, Algemeen Ziekenhuis Sint Lucas, Brugge, Belgium ; Department of Gastroenterology and Hepatology, Cliniques Universitaires St-Luc, Brussels, Belgium ; Service de Gastro-entérologie, Bouge, Belgium ; Boitsfort Medical Center, Brussels, Belgium
Vergauwe, Philippe; Dienst Gastro Enterologie, Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium ; Department of Gastroenterology and Hepatology, Centre hospitalier universitaire, Université catholique de Louvain Namur, Godinne University Hospital ; Medical Research Consultant, Yvoir, Chaumont-Gistoux, Belgium
Roey, Guy; Department of Gastroenterology, Sint Elisabeth Ziekenhuis, Turnhout, Belgium
Latour, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Piessevaux, Hubert; Maagdarm en Leverziekten, Algemeen Ziekenhuis Sint Lucas, Brugge, Belgium ; Department of Gastroenterology and Hepatology, Cliniques Universitaires St-Luc, Clinique Saint Luc, Brussels, Belgium ; Service de Gastro-entérologie, Bouge, Belgium ; Boitsfort Medical Center, Brussels, Belgium
Maldague, Philippe; Maagdarm en Leverziekten, Algemeen Ziekenhuis Sint Lucas, Brugge, Belgium ; Ziekenhuis Oost-Limburg, Genk, Belgium, ; Sint Vincentius Ziekenhuis, Antwerpen, Belgium ; Department of Gastroenterology and Hepatology, Cliniques Universitaires St-Luc, Clinique Saint Luc, Brussels, Belgium ; Service de Gastro-entérologie, Bouge, Belgium ; Boitsfort Medical Center, Brussels, Belgium
Wuestenberghs, Fabien ; Dienst Gastro Enterologie, Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium ; Department of Gastroenterology and Hepatology, Centre hospitalier universitaire, Université catholique de Louvain Namur, Godinne University Hospital ## Medical Research Consultant, Yvoir, Chaumont-Gistoux, Belgium
Vandenberghe, Alain; Dienst Gastro Enterologie, Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium ; Department of Gastroenterology, Sint Elisabeth Ziekenhuis, Turnhout, Belgium ; Department of Gastroenterology and Hepatology, Centre hospitalier universitaire, Université catholique de Louvain Namur, Godinne University Hospital ; Medical Research Consultant, Yvoir, Chaumont-Gistoux, Belgium,
Tack, Jan ; Translational Research Center for Gastrointestinal Diseases, University of Leuven, Leuven, Belgium ; Department of Gastroenterology, Sint Elisabeth Ziekenhuis, Turnhout, Belgium
Mahadeva, S., Goh, K.L., Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol 12 (2006), 2661–2666.
Piessevaux, H., De Winter, B., Louis, E., et al. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil 21 (2009), 378–388.
Tack, J., Talley, N.J., Camilleri, M., et al. Functional gastroduodenal disorders. Gastroenterology 130 (2006), 1466–1479.
Tack, J., Talley, N.J., Functional dyspepsia–symptoms, definitions and validity of the Rome III criteria. Nat Rev Gastroenterol Hepatol 10 (2013), 134–141.
Aro, P., Talley, N.J., Ronkainen, J., et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology 137 (2009), 94–100.
Zagari, R.M., Law, G.R., Fuccio, L., et al. Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology 138 (2010), 1302–1311.
Choung, R.S., Locke, G.R., Schleck, C.D., et al. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol 102 (2007), 1983–1989.
van Kerkhoven, L.A., Laheij, R.J., Meineche-Schmidt, V., et al. Functional dyspepsia: not all roads seem to lead to Rome. J Clin Gastroenterol 43 (2009), 118–122.
Wang, A.J., Liao, X.H., Xiong, L.S., et al. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria. BMC Gastroenterol, 8, 2008, 43.
Arts, J., Bourgeois, S., Claessens, C., et al. Discriminant value of dyspepsia subgroups according to the Rome III consensus in dyspeptic patients referred for upper gastrointestinal endoscopy (abstr). Gastroenterology 134:Suppl 1 (2008), A–627.
Bisschops, R., Karamanolis, G., Arts, J., et al. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut 57 (2008), 1495–1503.
Vanheel, H., Vanuytsel, T., Van Oudenhove, L., et al. Postprandial symptoms originating from the stomach in functional dyspepsia. Neurogastroenterol Motil, 25, 2013 911–e703.
Farré, R., Vanheel, H., Vanuytsel, T., et al. In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity. Gastroenterology 145 (2013), 566–573.
Carbone, F., Holvoet, L., Tack, J., Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap. Neurogastroenterol Motil 27 (2015), 1069–1074.
Aziz, I., Palsson, O.S., Törnblom, H., et al. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol 3 (2018), 252–262.
Van den Houte, K., Carbone, F., Tack, J., Postprandial distress syndrome: stratification and management. Expert Rev Gastroenterol Hepatol 3 (2019), 337–343.
Tack, J., Van den Houte, K., Carbone, F., The unfulfilled promise of prokinetics for functional dyspepsia/postprandial distress syndrome. Am J Gastroenterol 114 (2019), 204–206.
Tack, J., Van den Houte, K., Carbone, F., Gastroduodenal motility disorders. Curr Opin Gastroenterol 34 (2018), 428–435.
Camilleri, M., Talley, N.J., Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil 16 (2004), 135–142.
Tack, J., Bisschops, R., Sarnelli, G., Pathophysiology and treatment of functional dyspepsia. Gastroenterology 127 (2004), 1239–1255.
Drossman, D.A., Thompson, G.W., Talley, N.J., et al. Identification of subgroups of functional gastrointestinal disorders. Gastroenterol Int 3 (1990), 159–172.
Talley, N.J., Stanghellini, V., Heading, R.C., et al. Functional gastroduodenal disorders. Gut 45:Suppl 2 (1999), II37–II42.
Talley, N.J., Locke, G.R., Lahr, B.D., et al. Predictors of the placebo response in functional dyspepsia. Aliment Pharmacol Ther 23 (2006), 923–936.
Carbone, F., Vanuytsel, T., Tack, J., Analysis of postprandial symptom patterns in subgroups of patients with Rome III or Rome IV functional dyspepsia. Clin Gastroenterol Hepatol 18 (2020), 838–846.
Russo, F., Chimienti, G., Clemente, C., et al. Gastric activity and gut peptides in patients with functional dyspepsia: postprandial distress syndrome versus epigastric pain syndrome. J Clin Gastroenterol 51 (2017), 136–144.
Di Stefano, M., Miceli, E., Tana, P., et al. Fasting and postprandial gastric sensorimotor activity in functional dyspepsia: postprandial distress vs. epigastric pain syndrome. Am J Gastroenterol 109 (2014), 1631–1639.
Hsu, Y.C., Liou, J.M., Yang, T.H., et al. Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?. J Gastroenterol 46 (2011), 183–190.
Suzuki, H., Kusunoki, H., Kamiya, T., et al. Effect of lansoprazole on the epigastric symptoms of functional dyspepsia (ELF study): a multicentre, prospective, randomized, double-blind, placebo-controlled clinical trial. United European Gastroenterol J 1 (2013), 445–452.
Carbone, F., Vandenberghe, A., Holvoet, L., et al. 383 - The therapeutic outcome of itopride in functional dyspepsia postprandial distress syndrome: a double-blind randomized, multicenter, placebo-controlled study. Gastroenterology 154 (2018), S-91–1.
